Wanda L. Salzer

Uniformed Services University of the Health Sciences

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Genomic Determinants of Outcome in Acute Lymphoblastic Leukemia”.

Genomic Determinants of Outcome in Acute Lymphoblastic Leukemia

Journal of Clinical Oncology(2024)10.1200/jco.23.02238

N/A

1.2DataRank · unranked

58 citations

Wenan Chen, Chunxu Qu, Zhongshan Cheng, Dale J. Hedges, Abdelrahman Elsayed +32 more

A phase 3 trial of inotuzumab ozogamicin for high-risk B-ALL: Second safety phase results from Children’s Oncology Group AALL1732.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10016

N/A

0.464DataRank · unranked

21 citations

Jennifer L. McNeer, Susan R. Rheingold, Meenakshi Devidas, Zhiguo Chen, Deepa Bhojwani +12 more

Comparison of chemotherapy dose intensity for AYAs on COG AALL1131 versus CALGB 10403.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10520

N/A

0.104DataRank · unranked

1 citations

Lingyun Ji, Xinxin Xu, Michael J. Burke, Wanda L. Salzer, Meenakshi Devidas +10 more

Outstanding outcomes in infants with KMT2A-germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children’s Oncology Group AALL0631 trial

Haematologica(2022)10.3324/haematol.2021.280146

N/A

0DataRank · unranked

19 citations

John A. Kairalla, Joanne M. Hilden, ZoAnn E. Dreyer, Andrew J. Carroll, Nyla A. Heerema +12 more

Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials

The Lancet Haematology(2023)10.1016/s2352-3026(22)00371-4

N/A

0DataRank · unranked

68 citations

Yunfeng Dai, Zhiguo Chen, Lena E. Winestone, David T. Teachey, Kira Bona +26 more

Impaired neurocognitive functioning 3 months following diagnosis of high‐risk acute lymphoblastic leukemia: A report from the Children's Oncology Group

Pediatric Blood & Cancer(2023)10.1002/pbc.30350

N/A

0DataRank · unranked

12 citations

John A. Kairalla, Anthony Gioia, Hannah Weisman, Meera Gurung, Robert B. Noll +7 more

Impact of Propofol Exposure on Neurocognitive Outcomes in Children With High-Risk B ALL: A Children's Oncology Group Study

Journal of Clinical Oncology(2024)10.1200/jco.23.01989

N/A

0DataRank · unranked

27 citations

John A. Kairalla, Sumit Gupta, Emily Hibbitts, Hannah Weisman, Doralina L. Anghelescu +12 more

Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children’s Oncology Group Report

Leukemia(2024)10.1038/s41375-024-02166-1

N/A

0DataRank · unranked

22 citations

Mignon L. Loh, Michael J. Borowitz, Sumit Gupta, Karen R. Rabin, Patrick A. Zweidler‐McKay +26 more

Outcomes in children with Down syndrome (DS) and B-lymphoblastic leukemia (B-ALL): A Children’s Oncology Group (COG) report.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10510

N/A

0DataRank · unranked

7 citations

Zhiguo Chen, Meenakshi Devidas, Johann Hitzler, Eric Larsen, Michael J. Burke +14 more

Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia

Research Square(2024)10.21203/rs.3.rs-5292018/v1

N/A

0DataRank · unranked

3 citations

Emily Ashcraft, Ti‐Cheng Chang, Kathryn G. Roberts, Samuel W. Brady, Yiping Fan +22 more

Prognostic impact of minimal residual disease at the end of consolidation in NCI standard‐risk B‐lymphoblastic leukemia: A report from the Children's Oncology Group

Pediatric Blood & Cancer(2021)10.1002/pbc.28929

N/A

0DataRank · unranked

13 citations

Yunfeng Dai, Meenakshi Devidas, Karen R. Rabin, Patrick A. Zweidler‐McKay, Anne Angiolillo +12 more

Minimal residual disease at end of induction and consolidation remain important prognostic indicators for newly diagnosed children and young adults with very high-risk (VHR) B-lymphoblastic leukemia (B-ALL): Children’s Oncology Group AALL1131.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10004

N/A

0DataRank · unranked

4 citations

Michael J. Burke, Meenakshi Devidas, Yunfeng Dai, Nyla A. Heerema, Andrew J. Carroll +11 more